Evidence map›Paper›PMID 24033550›Full record

ArticleAlcoholism, clinical and experimental research2014

Psychiatric comorbidity and 12-step participation: a longitudinal investigation of treated young adults.

Brandon G Bergman, M Claire Greene, Bettina B Hoeppner, Valerie Slaymaker, John F Kelly

Open access · greenAbstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Brandon G BergmanCenter for Addiction Medicine , Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
M Claire Greene
Bettina B Hoeppner
Valerie Slaymaker
John F Kelly
Harvard University · USMassachusetts General Hospital · USFoundation Center · US

Funding

Dynamic Processes of Smoking CessationK01DA027097 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI HOEPPNER, BETTINA B. · 2010 to 2014
$834k
MECHANISMS AND MODERATORS OF CHANGE AMONG YOUTH TREATED FOR ALCOHOL USE DISORDERSR21AA018185 · NIAAA · MASSACHUSETTS GENERAL HOSPITAL · PI KELLY, JOHN F. · 2010 to 2011
$481k
NIAAA NIH HHS 1R21AA018185-01A2NIAAA NIH HHS R21 AA018185NIDA NIH HHS K01 DA027097NIDA NIH HHS K01DA027097
6 · The paper itself

Abstract

backgroundEvidence indicates that 12-step mutual-help organizations (MHOs), such as Alcoholics Anonymous (AA) and Narcotics Anonymous (NA), can play an important role in extending and potentiating the recovery benefits of professionally delivered addiction treatment among young adults with substance use disorders (SUD). However, concerns have lingered regarding the suitability of 12-step organizations for certain clinical subgroups, such as those with dual diagnosis (DD). This study examined the influence of diagnostic status (DD vs. SUD-only) on both attendance and active involvement (e.g., having a sponsor, verbal participation during meetings) in, and derived benefits from, 12-step MHOs following residential treatment.

methodsYoung adults (N = 296; 18 to 24 years old; 26% female; 95% Caucasian; 47% DD [based on structured diagnostic interview]), enrolled in a prospective naturalistic study of SUD treatment effectiveness, were assessed at intake and 3, 6, and 12 months posttreatment on 12-step attendance/active involvement and percent days abstinent (PDA). t-Tests and lagged, hierarchical linear models (HLM) examined the extent to which diagnostic status influenced 12-step participation and any derived benefits, respectively.

resultsFor DD and SUD-only patients, posttreatment attendance and active involvement in 12-step organizations were similarly high. Overall, DD patients had significantly lower PDA relative to SUD-only patients. All patients appeared to benefit significantly from attendance and active involvement on a combined 8-item index. Regarding the primary effects of interest, significant differences did not emerge in derived benefit between DD and SUD-only patients for either attendance (p = 0.436) or active involvement (p = 0.062). Subsidiary analyses showed, however, that DD patients experienced significantly greater abstinence-related benefit from having a 12-step sponsor.

conclusionsDespite concerns regarding the clinical utility of 12-step MHOs for DD patients, findings indicate that DD young adults participate and benefit as much as SUD-only patients, and may benefit more from high levels of active involvement, particularly having a 12-step sponsor. Future work is needed to clarify how active 12-step involvement might offset the additional recovery burden of a comorbid mental illness on substance use outcomes.

Indexed as

Alcoholics AnonymousAdolescentAlcoholismDiagnosis, Dual (Psychiatry)FemaleFollow-Up StudiesHumansLongitudinal StudiesMaleMental DisordersMotivationNeuropsychological TestsPatient CompliancePsychiatric Status Rating ScalesSelf EfficacySocioeconomic Factors12-Step ParticipationCo-Occurring DisordersDual DiagnosisYoung Adults

Identifiers

PMID24033550
PMCPMC3946781
OpenAlexW2115939590

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.